Home » Provectus: Data for PV-10 Shows Markedly Longer Overall Survival
Provectus: Data for PV-10 Shows Markedly Longer Overall Survival
Provectus Pharmaceuticals, Inc. … announced that initial one year overall survival data from the first 20 subjects in the current Phase 2 trial
showed comparable trends to Phase 1 survival data.
Genetic Engineering & Biotechnology News
Genetic Engineering & Biotechnology News
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May